Drug interactions
Idarubicin + Meningococcal group b vaccine
Severity: Minor
Idarubicin and Meningococcal group b vaccine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Chemotherapy-induced immunosuppression may reduce the antibody response to meningococcal B vaccine, leaving patients less protected. The vaccine is non-live, so it is safe but may be less effective.
What this interaction means in plain words
Idarubicin and Meningococcal group b vaccine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Cytotoxic myelosuppression and lymphopenia blunt the immune response to vaccination.
What to do
Vaccinate before chemotherapy when possible, ideally at least two weeks beforehand. Otherwise vaccinate after immune recovery or consider checking antibody response if indicated.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Idarubicin and Meningococcal group b vaccine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Idarubicin
- Adenovirus types 4 and 7 live + Idarubicin Contraindicated
- Belatacept + Idarubicin Major
- Cyclophosphamide + Idarubicin Major
- Deferiprone + Idarubicin Major
- Dengue vaccine + Idarubicin Major
- Etrasimod + Idarubicin Major
Frequently asked questions
Can I take Idarubicin with Meningococcal group b vaccine?
MediHelp rates the interaction as minor. Idarubicin and Meningococcal group b vaccine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Chemotherapy-induced immunosuppression may reduce the antibody response to meningococcal B vaccine, leaving patients less protected. The vaccine is non-live, so it is safe but may be less effective.
How serious is the interaction between Idarubicin and Meningococcal group b vaccine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate before chemotherapy when possible, ideally at least two weeks beforehand. Otherwise vaccinate after immune recovery or consider checking antibody response if indicated.
What other medicines interact with Idarubicin?
MediHelp also lists interactions of Idarubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclophosphamide. The full list is on the Idarubicin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
